Phathom Pharmaceuticals, Inc.
$6.92
-0.58 (-7.73%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -10.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -30.1%
Own PHAT?
See how PHAT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.